Recommendation to treat continuous variable errors like attribute errors
-
Jan S. Krouwer
Abstract
Clinical laboratory errors can be considered as either belonging to attribute or continuous variables. Attribute errors are usually considered to be pre- or post-analytical errors, whereas continuous variable errors are analytical. Goals for each error type are different. Error goals for continuous variables are often specified as limits that contain 95% of the results, whereas attribute error goals are specified as allowed error rates for serious events. This leads to a discrepancy, because for a million results, there can be up to 50,000 medically unacceptable analytical errors, but allowable pre- and post-analytical error rates are much lower than 5%. Steps to remedy this are to classify analytical error rates into severity categories, exemplified by existing glucose error grids. The results in each error grid zone are then counted, as has been recommended by the Food and Drug Administration (FDA). This in effect transforms the continuous variable errors into attribute errors. This is an improvement over current practices for analytical errors, whereby the use of uncertainty intervals is recommended that include only 95% of the results (i.e., leaves out the worst 5%), and it is precisely this 5% of results that are likely to be in the most severe zones of an error grid.
Clin Chem Lab Med 2006;44:797–8.
References
1. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academy Press, 2000.Search in Google Scholar
2. The Lewin Group. The value of diagnostics: innovation, adoption and diffusion into health care. http://www.advamed.org/publicdocs/thevalueofdiagnostics.pdf, www.fda.gov/cdrh/postmarket/mdpi-report.pdf (accessed March 2, 2006).Search in Google Scholar
3. Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997;1348–51.10.1093/clinchem/43.8.1348Search in Google Scholar
4. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48:691–8.10.1093/clinchem/48.5.691Search in Google Scholar
5. Howanitz PJ. Errors in laboratory medicine: practical lessons to improve patient safety. Arch Pathol Lab Med 2005; 129:1252–61.10.5858/2005-129-1252-EILMPLSearch in Google Scholar PubMed
6. ISO 15197. In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. http://www.ISO.org.Search in Google Scholar
7. Healthcare failure mode and effect analysis (HFMEA). VA National Center for Patient Safety. http://www.va.gov/ncps/SafetyTopics/HFMEA/HFMEAmaterials.pdf (accessed March 3, 2006).Search in Google Scholar
8. Dimech W, Francis B, Kox J, Roberts G. Calculating uncertainty of measurement for serology assays by use of precision and bias. Clin Chem 2006; 52:526–9.10.1373/clinchem.2005.056689Search in Google Scholar PubMed
9. Eurachem/CITAC. Quantifying uncertainty in analytical measurement. http://www.measurementuncertainty.org/mu/QUAM2000-1.pdf (accessed March 1, 2006).Search in Google Scholar
10. Cole LA, Rinne KM, Shahabi S, Omrani A. False positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clin Chem 1999; 45:313–4.10.1093/clinchem/45.2.313Search in Google Scholar
11. Public Health Dispatch. Adverse events and deaths associated with laboratory errors at a hospital – Pennsylvania, 2001. MMWR Morb Mortal Wkly Rep 2001;50(33):10–1, http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5033a4.htm (accessed March 2, 2006).Search in Google Scholar
12. Krouwer JS. A critique of the GUM method of estimating and reporting uncertainty in diagnostic assays. Clin Chem 2003; 49:1818–21.10.1373/clinchem.2003.019505Search in Google Scholar PubMed
13. Krouwer JS. An improved FMEA (failure mode effects analysis) for hospitals. Arch Pathol Lab Med 2004; 128:663–7.10.5858/2004-128-663-AIFMEASearch in Google Scholar PubMed
14. Clark WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987; 10:622–8.10.2337/diacare.10.5.622Search in Google Scholar PubMed
15. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000; 23:1143–8.10.2337/diacare.23.8.1143Search in Google Scholar PubMed
16. Draft guidance for industry and FDA staff. Recommendations for clinical laboratory improvement, amendments of 1988 (CLIA) waiver applications. http://www.fda.gov/cdrh/oivd/guidance/1171.pdf (accessed March 2, 2006).Search in Google Scholar
17. Kratz A, Januzzi JL, Lewandrowski K, Lee-Lewandrowski E. Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes. Arch Pathol Lab Med 2002; 126:1487–93.10.5858/2002-126-1487-PPVOAPSearch in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Flow-cytometric immunophenotyping of normal and malignant lymphocytes
- Recommendation to treat continuous variable errors like attribute errors
- Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia
- Lack of association between α2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation – preliminary report
- Prognostic value of homocysteinemia in patients with congestive heart failure
- Comparability of indices for insulin resistance and insulin secretion determined during oral glucose tolerance tests
- Evaluation of clinical markers of atherosclerosis in young and elderly Japanese adults
- Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease
- Cardiac troponin T and amino-terminal pro-natriuretic peptide concentrations in fetuses in the second trimester and in healthy neonates
- Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method
- Fluorimetric determination of activity and isoenzyme composition of N-acetyl-β-D-hexosaminidase in seminal plasma of fertile men and infertile patients with secretory azoospermia
- Increased fructosamine in non-diabetic rheumatoid arthritis patients: role of lipid peroxides and glutathione
- Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness – a multiparametric study in rats
- Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias
- Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey
- Use of haemolysis index to estimate potassium concentration in in-vitro haemolysed serum samples
- Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy
- Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer
- Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices
- Hypothesis on interferences in kinetic interaction of microparticles in solution (KIMS) technology
- Comparability of point-of-care whole-blood electrolyte and substrate testing using a Stat Profile Critical Care Xpress analyzer and standard laboratory methods
- Determination of the length of sedimentation reaction in blood using the TEST 1 system: comparison with the Sedimatic 100 method, turbidimetric fibrinogen levels, and the influence of M-proteins
- Transcriptions and ISO 15189
- Falsely elevated troponin I attributed to inadequate centrifugation using the Access® immunoassay analyzer
- Interference of sulfamethoxazole in Capillarys® electrophoresis
Articles in the same Issue
- Flow-cytometric immunophenotyping of normal and malignant lymphocytes
- Recommendation to treat continuous variable errors like attribute errors
- Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia
- Lack of association between α2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation – preliminary report
- Prognostic value of homocysteinemia in patients with congestive heart failure
- Comparability of indices for insulin resistance and insulin secretion determined during oral glucose tolerance tests
- Evaluation of clinical markers of atherosclerosis in young and elderly Japanese adults
- Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease
- Cardiac troponin T and amino-terminal pro-natriuretic peptide concentrations in fetuses in the second trimester and in healthy neonates
- Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method
- Fluorimetric determination of activity and isoenzyme composition of N-acetyl-β-D-hexosaminidase in seminal plasma of fertile men and infertile patients with secretory azoospermia
- Increased fructosamine in non-diabetic rheumatoid arthritis patients: role of lipid peroxides and glutathione
- Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness – a multiparametric study in rats
- Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias
- Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey
- Use of haemolysis index to estimate potassium concentration in in-vitro haemolysed serum samples
- Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy
- Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer
- Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices
- Hypothesis on interferences in kinetic interaction of microparticles in solution (KIMS) technology
- Comparability of point-of-care whole-blood electrolyte and substrate testing using a Stat Profile Critical Care Xpress analyzer and standard laboratory methods
- Determination of the length of sedimentation reaction in blood using the TEST 1 system: comparison with the Sedimatic 100 method, turbidimetric fibrinogen levels, and the influence of M-proteins
- Transcriptions and ISO 15189
- Falsely elevated troponin I attributed to inadequate centrifugation using the Access® immunoassay analyzer
- Interference of sulfamethoxazole in Capillarys® electrophoresis
